Onconetix, Inc. Stock Issued During Period, Shares, Restricted Stock Award, Gross
Onconetix, Inc. (ONCO) reported Stock Issued During Period, Shares, Restricted Stock Award, Gross of 487.50 thousand shares for the 0-month period ending 2023-05-09, per its 10-Q filed 2023-05-12.
Discontinued › Shareholders' Equity › Shares Granted or Issued, Share-Based Payment Arrangement
us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross · last filed 2024-04-11
- 2023-05-09: Stock Issued During Period, Shares, Restricted Stock Award, Gross 0 month 487.50K shares; Stock Issued During Period, Shares, Restricted Stock Award, Gross 487.50K shares.
- 2022-10-31: Stock Issued During Period, Shares, Restricted Stock Award, Gross 1 month 93.47K shares.
| Period end | Stock Issued During Period, Shares, Restricted Stock Award, Gross 0 month | Stock Issued During Period, Shares, Restricted Stock Award, Gross | Stock Issued During Period, Shares, Restricted Stock Award, Gross 1 month |
|---|---|---|---|
| 2023-05-09 | 487.50K shares 10-Q · filed 2023-05-12 | 487.50K shares 10-Q · filed 2023-11-17 | |
| 2022-10-31 | 93.47K shares 10-K · filed 2024-04-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |